|
Cardinal Health has designed and made available to their customers
the Nuclear Medicine Patient Card.
During this time of heightened security interest, this card helps
the traveling nuclear medicine patient provide an explanation to
security or law enforcement personnel in case safety-monitoring
equipment is triggered. This card includes the patient name, facility
name, procedure date, radionuclide used, its half-life, its activity
and emissions, its expiration date and a contact name and number
to verify the procedure. These cards were developed to assist nuclear
medicine practitioners meet this challenging patient need.
On December 9, 2003 the NRC issued "NRC
Information Notice 2003-22: Heightened Awareness for Patients Containing
Detectable Amounts
of Radiation from Medical Administration" addressing this
situation. This information notice recommended consulting with
patients in advance of release from the hospital and to provide
written documentation for law enforcement regarding the safety
of the patient.
On November 30, 2004 at the meeting of the Radiological Society
of North America, Dr. Lionel Zuckier, M.D., a professor of radiology
at the University of Medicine and Dentistry of New Jersey, presented
a poster that identified that patients who have undergone certain
nuclear medicine procedures are at risk of triggering sensitive
radiation detectors. Dr. Zuckier's findings indicate that trace
quantities of radionuclides could set off radiation detectors for
a period of time after the actual exam or therapy. These include:
| 18F
FDG |
|
. . . |
|
1 day |
| 99mTc labeled compounds |
|
. . . |
|
up to 3 days |
| 123I NaI |
|
. . . |
|
up to 3 days |
| 111In labeled compounds |
|
. . . |
|
14 to 17 days |
| 201TI
Thallous Chloride |
|
. . . |
|
up to 30 days |
| 67Ga Citrate |
|
. . . |
|
up to 30 days |
| 131I
NaI or Bexxar |
|
. . . |
|
up to 95 days |
The Nuclear Medicine Patient Card is another innovative service from
Cardinal Health to assist the nuclear medicine community.
|